Literature DB >> 8979283

Effect of maternal diabetes upon fetal rat myocardial and skeletal muscle glucose transporters.

R E Schroeder1, C L Doria-Medina, U G Das, W I Sivitz, S U Devaskar.   

Abstract

We investigated the effect of streptozotocin-induced short-term maternal diabetes upon fetal rat myocardial and skeletal muscle glucose transporter Glut 1 (basal form) and Glut 4 (insulin-responsive form) protein concentrations by Western blot analysis. In the severely diabetic group (SEVERE-D, n = 17), a 3-fold increase in maternal and fetal glucose concentrations (p < 0.01) was associated with a 3-fold decline in maternal (p < 0.01) with no change in fetal insulin levels when compared with the streptozotocin-treated nondiabetic (n = 10) and vehicle-treated control (control, n = 14) groups. These changes in the SEVERE-D group when compared with controls were associated with a 30 and 65% decline, respectively, in fetal myocardial and skeletal muscle (forelimb and hind limb) Glut 1 protein concentrations. The fetal myocardium also demonstrated a 45% decline in Glut 4 protein levels. Fetal skeletal muscle Glut 4 protein, which was expressed only at very low levels in controls showed no change in SEVERE-D. Immunohistochemical analysis revealed a myocyte-plasma membrane association of Glut 1 and an intracellular Glut 4 distribution in the fetal myocardium and skeletal muscle. No Glut 1 immunoreactivity was noted in either the fetal myocardial or skeletal muscle perineural sheaths, blood vessels, or the entrapped fetal red blood cells. This subcellular localization pattern was unaltered in all three treatment groups. We conclude that maternal diabetes causing fetal hyperglycemia with normoinsulinemia suppresses fetal myocardial Glut 1 and Glut 4 and fetal skeletal muscle Glut 1. The decline in the plasma membrane associated Glut 1 concentrations may serve a protective function by reducing the glucose transport rate into fetal myocardial and skeletal muscle cells, which otherwise could be vulnerable to high circulating glucose. The in-utero maternal diabetes induced decrease in fetal myocardial intracellular-Glut 4 concentration could herald the emergence of insulin resistance.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8979283     DOI: 10.1203/00006450-199701000-00002

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  6 in total

Review 1.  Will the original glucose transporter isoform please stand up!

Authors:  Anthony Carruthers; Julie DeZutter; Amit Ganguly; Sherin U Devaskar
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-08-18       Impact factor: 4.310

Review 2.  Maturation of fatty acid and carbohydrate metabolism in the newborn heart.

Authors:  A O Makinde; P F Kantor; G D Lopaschuk
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

3.  Myocardial macronutrient transporter adaptations in the adult pregestational female intrauterine and postnatal growth-restricted offspring.

Authors:  Afshan Abbasi; Manikkavasagar Thamotharan; Bo-Chul Shin; Maria C Jordan; Kenneth P Roos; Andreas Stahl; Sherin U Devaskar
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-02-14       Impact factor: 4.310

Review 4.  Regulation of cardiac energy metabolism in newborn.

Authors:  Arzu Onay-Besikci
Journal:  Mol Cell Biochem       Date:  2006-05-03       Impact factor: 3.396

5.  Programming of growth, insulin resistance and vascular dysfunction in offspring of late gestation diabetic rats.

Authors:  Emily M Segar; Andrew W Norris; Jian-Rong Yao; Shanming Hu; Stacia L Koppenhafer; Robert D Roghair; Jeffrey L Segar; Thomas D Scholz
Journal:  Clin Sci (Lond)       Date:  2009-07-02       Impact factor: 6.124

Review 6.  Lifetime consequences of abnormal fetal pancreatic development.

Authors:  K Holemans; L Aerts; F A Van Assche
Journal:  J Physiol       Date:  2003-01-17       Impact factor: 5.182

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.